| IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and … M Iwaszko, J Wielińska, J Świerkot, K Kolossa, R Sokolik, B Bugaj, ... Frontiers in Immunology 12, 631603, 2021 | 24 | 2021 |
| Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter Trypanosoma brucei AH Alghamdi, JC Munday, GD Campagnaro, D Gurvic, F Svensson, ... Elife 9, e56416, 2020 | 22 | 2020 |
| Interleukin 6 gene polymorphism is associated with protein serum level and disease activity in Polish patients with rheumatoid arthritis J Wielińska, M Dratwa, J Świerkot, L Korman, M Iwaszko, B Wysoczańska, ... HLA 92, 38-41, 2018 | 14 | 2018 |
| Polymorphisms within Genes Coding for IL‐17A and F and Their Receptor as Clinical Hallmarks in Ankylosing Spondylitis J Wielińska, J Świerkot, K Kolossa, B Bugaj, ... Mediators of Inflammation 2021 (1), 3125922, 2021 | 13 | 2021 |
| miRNAs as potential biomarkers of treatment outcome in rheumatoid arthritis and ankylosing spondylitis J Wielinska, K Bogunia-Kubik Pharmacogenomics 22 (5), 291-301, 2021 | 9 | 2021 |
| Exploring the extracellular vesicle MicroRNA expression repertoire in patients with rheumatoid arthritis and ankylosing spondylitis treated with TNF inhibitors J Wielińska, RE Crossland, P Łacina, J Świerkot, B Bugaj, AM Dickinson, ... Disease Markers 2021 (1), 2924935, 2021 | 8 | 2021 |
| Shared epitope and polymorphism of MICA and NKG2D encoding genes in Greek and Polish patients with rheumatoid arthritis J Wielińska, K Tarassi, M Iwaszko, K Kościńska, B Wysoczańska, E Mole, ... Central European Journal of Immunology 46 (1), 92-98, 2021 | 8 | 2021 |
| Polymorphisms within the RANK and RANKL Encoding Genes in Patients with Rheumatoid Arthritis: Association with Disease Progression and Effectiveness of the … J Wielińska, K Kolossa, J Świerkot, M Dratwa, M Iwaszko, B Bugaj, ... Archivum Immunologiae et Therapiae Experimentalis 68, 1-9, 2020 | 7 | 2020 |
| Differential expression of miRNAs from extracellular vesicles in chronic graft-versus-host disease: A preliminary study P Lacina, RE Crossland, J Wielinska, A Czyz, A Szeremet, M Ussowicz, ... Adv Clin Exp Med 32, 539-44, 2022 | 6 | 2022 |
| VDR Polymorphic variants are related to improvements in CRP and disease activity in patients with axial spondyloarthritis that undergo anti-TNF treatment B Bugaj, J Wielińska, J Świerkot, K Bogunia-Kubik, K Górna Genes 13 (10), 1873, 2022 | 4 | 2022 |
| Searching for New Genetic Biomarkers of Axial Spondyloarthritis B Bugaj, J Wielińska, K Bogunia-Kubik, J Świerkot Journal of Clinical Medicine 11 (10), 2912, 2022 | 3 | 2022 |
| Disease differentiation and monitoring of anti-TNF treatment in rheumatoid arthritis and spondyloarthropathies K Bogunia-Kubik, W Wojtowicz, J Swierkot, KA Mielko, B Qasem, ... International Journal of Molecular Sciences 22 (14), 7389, 2021 | 3 | 2021 |
| Differential expression of miRNAs in chronic Graft-versus-Host Disease K Bogunia-Kubik, P Lacina, RE Crossland, J Wielinska, A Czyz, ... HLA 95 (4), 293-294, 2020 | 1 | 2020 |
| Genetic variability of three common NK and γδ T cell receptor genes (FCγ3R, NCR3, and DNAM-1) and their role in Polish patients with rheumatoid arthritis and ankylosing spondylitis S Biały, M Iwaszko, J Świerkot, K Kolossa, J Wielińska, S Jeka, ... Immunologic Research, 1-12, 2024 | | 2024 |
| Association of MICA and NKG2D genetic variants with disease susceptibility and outcome of anti-TNF therapy in patients with axial spondyloarthritis J Wielińska, B Bugaj, J Świerkot, K Kolossa, M Iwaszko, S Jeka, ... Clinical and Experimental Rheumatology, 2024 | | 2024 |
| Can miRNA profiling be helpful in distinguishing rheumatic disorders? M Chaszczewska-Markowska, K Gębura, J Świerkot, R Sokolik, B Bugaj, ... | | 2022 |
| AB0763 Personal approach in axial spondyloarthropathy management B Bugaj, J Wielinska, J Swierkot, K Bogunia-Kubik Annals of the Rheumatic Diseases 81 (Suppl 1), 1508-1508, 2022 | | 2022 |
| Materials and Methods: In total, 735 patients diagnosed with RA, AS, and PsA and 229 healthy individuals were enrolled in the study. Genotyping for three single nucleotide … M Iwaszko, J Wielinska, J Swierkot, K Kolossa, R Sokolik, B Bugaj, ... Recent Advances in Potential Biomarkers for Rheumatic Diseases and in Cell …, 2022 | | 2022 |
| CHANGES IN THE MIRNA REPERTOIRE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS TREATED WITH TNF-INHIBITORS J Wielinska, RE Crossland, P Lacina, J Swierkot, B Bugaj, A Dickinson, ... HLA 95 (4), 364-365, 2020 | | 2020 |
| AB0781 ASSOCIATION OF MICA POLYMORPHISM AND SERUM LEVELS WITH PREDISPOSITION TO PSORIATIC ARTHRITIS R Sokolik, M Dratwa, J Wielinska, M Iwaszko, ... Annals of the Rheumatic Diseases 78 (Suppl 2), 1860-1860, 2019 | | 2019 |
